Purple Book product · Reference 351(a)
Alphanine, Alphanine Hp, Alphanine Sd
Coagulation Factor IX (Human)
Dec 31, 1990
Approved
Reference 351(a)
License type
Disc
Marketing
None
Listed patents
Sourced from the FDA Purple Book · verified Jul 02, 2026
Key dates
Approval
Approval date of this BLA submission.
Dec 31, 1990
36 yr 1 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
Dec 31, 1997
29 yr ago
Today
Pharmaceutical detail
Strength
250IU
Dosage form
Injection
Route
Intravenous
Presentation
Single-Dose Vial
Center
CBER
License number
1694
Product number
003
Submission type
Original
Supplement number
0
Change type
Not listed
Reference product family
View full familyThis is the reference (originator) product. No biosimilars or interchangeables reference it in the Purple Book yet.
3 additional BLA records for this product (other strengths or presentations) are in the same reference family.
Patent list
No patent-list records were published for this product. The Purple Book patent list reflects the statutory patent exchange under the BPCIA and is not exhaustive.
Source provenance
- advanced-searchAdvanced Search · Jul 02, 2026
- monthly-downloadMonthly download · Jul 02, 2026
Change history
- v6Jul 02, 2026
- v5Jul 02, 2026
- v4Jul 02, 2026
- v3Jul 02, 2026
- v2Jul 02, 2026
Frequently asked questions
Does Alphanine, Alphanine Hp, Alphanine Sd have approved biosimilars?
No 351(k) biosimilars or interchangeable biosimilars referencing Alphanine, Alphanine Hp, Alphanine Sd are listed in the FDA Purple Book yet.
What is Alphanine, Alphanine Hp, Alphanine Sd's BLA number?
Alphanine, Alphanine Hp, Alphanine Sd is licensed under BLA 103249, held by Grifols Biologicals LLC.
When was Alphanine, Alphanine Hp, Alphanine Sd approved by the FDA?
Alphanine, Alphanine Hp, Alphanine Sd was approved by the FDA on Dec 31, 1990.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

